本页面由Tiger Trade Technology Pte. Ltd.提供服务

武田制药

17.83
-0.2800-1.55%
盘后17.830.00000.00%19:01 EDT
成交量:263.13万
成交额:4,709.38万
市值:563.28亿
市盈率:79.34
高:18.12
开:18.12
低:17.78
收:18.11
52周最高:18.82
52周最低:12.99
股本:31.59亿
流通股本:30.57亿
量比:0.95
换手率:0.09%
股息:0.62
股息率:3.49%
每股收益(TTM):0.2247
每股收益(LYR):0.2245
净资产收益率:1.50%
总资产收益率:2.47%
市净率:1.17
市盈率(LYR):79.43

数据加载中...

2025/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/27

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/06/25

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/31

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities